Terminated PHASE4 INTERVENTIONAL 2-arm NCT02050230

Hemodynamic Effects of Stored Blood Transfusion in Intensive Care Patients

Sponsor: Medical University of Vienna

Updated 5 times since 2017 Last updated: Oct 26, 2016 Started: Jan 31, 2014 Primary completion: Jun 30, 2016 Completion: Jun 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Protracted recruitment of patients

Other terminated trials from Medical University of Vienna

See all terminations from Medical University of Vienna

Other Pulmonary Hypertension trials with similar outcome

Browse all Pulmonary Hypertension trials

This PHASE4 trial investigates Pulmonary Hypertension and is currently terminated or withdrawn. Medical University of Vienna leads this study, which shows 5 recorded versions since 2014 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE4
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE4
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE4

First recorded

Jan 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medical University of Vienna

Data source: Medical University of Vienna

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Vienna, Austria